The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer
Koji Takahashi(The University of Tokyo), Yataro Daigo(The University of Tokyo), Wataru Yasui(Hiroshima University), Eiju Tsuchiya(Kanagawa Prefectural Hospital Organization), Tatsuya Kato(Toranomon Hospital), Chiyuki Furukawa, Nobuhisa Ishikawa(The University of Tokyo), Satoshi Hayama(The University of Tokyo), Chie Suzuki(The University of Tokyo), Atsushi Takano(The University of Tokyo), Yusuke Nakamura(Rissho University), Tomoo Ito(Hokkaido University), Kouki Inai(Hiroshima University), Saburo Sone(Io Therapeutics (United States)), Hitoshi Nishimura(Tokushima University)
Cited by 134
Related Papers
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593